<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>489</id><JournalTitle>PCL SCAFFOLD FOR NEURONAL PROGENITAL CELLS DERIVED FROM CORD BLOOD: TO RECONSTITUTE NERVE TISSUE</JournalTitle><Abstract>Neural progenital cells derived from human umbilical cord blood (HUCB-NPCs) is an ethically uncontroversial source
of stem cells, able to differentiate into specific type of cells thats neuronal cells. The proliferative capacity of the HUCB-NPCs
was monitored by the MTT test over fabricated PCL scaffold while their ability to differentiate into neural-like cells by Reverse
Transcriptase (RT)-PCR. In preliminary experiments, human umbilical cord blood derived MNC cells cultured in vitro with
various growth factors substantiate mesenchymal cell morphology, and were positive by RT-PCR for Nestin (neural),GAPDH
(housekeeping gene), CD105 (endoglin), and CD90 (specific mesenchymal marker) markers and negative for Sox2 that
indicates all mononuclear cells (MNCs) converted to NPCs. Neural progenitalcells cultured on the polycaprolactone (PCL)
Scaffold i.e., PCL with polyethylene glycol(PEG) 4000 (5%,10%) & sucrose (5%,10%), fabricated by solvent casting &
particulate leaching method, in differentiating medium over 21 days which exhibited a good confinement to the polypeptide
domains of PCL. The number of cells attached increased linearly with the micro-film of PCL & PCL with Sucrose (5%, 10%).
This article provides state-of-the-art on interactions between neural progenital cells derived from human cord blood and
bioengineered surfaces</Abstract><Email>dhananiankita38@gmail.com</Email><articletype>Research</articletype><volume>5</volume><issue>7</issue><year>2014</year><keyword>Human umbilical cord blood,Neuronal progenital cells,Mononuclear cells,PCL scaffold</keyword><AUTHORS>Ankita Dhanani,Rajesh Patel,Himanshu patel</AUTHORS><afflication> S.K. Patel college of pharmaceutical education & research, Department of Pharmaceutical Biotechnology, Ganpat University, Kherva, Gujarat, India, S.K. Patel college of pharmaceutical education & research, Department of Pharmaceutical Biotechnology, Ganpat University, Kherva, Gujarat, India, Stem Cure Pvt. Ltd for regenerative medicine, Navrang pura, Ahmedabad, Gujarat, India</afflication></Article></Articles>